Skip to search formSkip to main contentSkip to account menu

GAL021

Known as: GAL-021 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Triazines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
High Efficacy by GAL-021: A Known Intravenous Peripheral Chemoreceptor Modulator that Suppresses BKCa-Channel Activity and Inhibits IK(M) or Ih
GAL-021 has recently been developed as a novel breathing control modulator. However, modifications of ionic currents produced by… 
2018
2018
Opioid-induced respiratory depression : implications & prevention
The goal of this thesis was to study the ability to reverse opioid-induced respiratory depression with respiratory stimulants… 
2013
2013
GAL‐021 increases CO2‐chemosensitivity at doses that do not stimulate minute ventilation
GAL‐021 is a novel chemical entity that inhibits BK channels on carotid body glomus type 1 cells and dose‐dependently stimulates… 
2012
2012
GAL‐021, a novel respiratory stimulant, attenuates opioid–induced respiratory depression without compromising analgesia
Opioid‐induced respiratory depression (OIRD) is a common side effect of opioid analgesics and can be life‐threatening, especially… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)